Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-10-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于取得两项医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of two medical device registration certificates issued by a regulatory authority. It includes product details and the impact on the company's business. The document is short (944 characters) and does not contain financial statements or detailed financial data. It is an announcement of a regulatory approval rather than a financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-10-11 Chinese
关于取得五项医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of five medical device registration certificates issued by a regulatory authority (Hunan Food and Drug Administration). It details the product names, registration numbers, validity periods, and intended uses. The announcement emphasizes the authenticity and completeness of the information and notes the impact on the company's business. The document is short (1662 characters) and does not contain financial statements, detailed financial analysis, or comprehensive report content. It is an official announcement about regulatory approvals rather than a financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2017-09-21 Chinese
关于参加2017年度投资者网上接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor online reception day event scheduled for September 12, 2017. It mentions that the company will communicate with investors regarding the 2017 half-year report, governance, strategy, and business conditions. However, the document itself does not contain any financial statements or substantive financial data. It is a notice about an event for investor interaction rather than a report or transcript. The document length is short (690 characters), and it serves as an announcement rather than the actual report or transcript. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2017-09-06 Chinese
关于收到《中国证监会行政许可项目审查一次反馈意见通知书》的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from a company regarding feedback received from the China Securities Regulatory Commission (CSRC) on an administrative licensing project review related to the company's issuance of shares to purchase assets. The content includes extensive requests for supplementary disclosures, clarifications, and opinions from independent financial advisors, lawyers, and accountants about the acquisition and related financial and legal matters. The document is not a financial report itself but rather a regulatory announcement about the review process and required responses. It does not contain actual financial statements or substantive financial data but is focused on regulatory compliance and procedural updates. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2017-08-30 Chinese
第三届董事会第十五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a board meeting resolution announcement from SanNuo Biological Sensor Co., Ltd. It includes the approval of an accounting policy change and the approval of the company's 2017 semi-annual report and its summary. The document states that the semi-annual report and its summary are published separately on the official disclosure website and in newspapers, indicating this document is an announcement of the board's approval rather than the full interim report itself. The document length is short (1367 characters), and it does not contain actual financial statements or substantive financial data, only the resolution and approval of the report. Therefore, according to the 'Menu vs Meal' rule, this is not the interim report itself but an announcement related to it. The best fitting category is Regulatory Filings (RNS), as it is a regulatory announcement about board resolutions and report approvals without the full report content.
2017-08-28 Chinese
2017年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2017 年半年度报告摘要" which translates to "2017 Half-Year Report Summary." It contains detailed financial data such as revenue, net profit, earnings per share, and asset information for the half-year period. It also includes management's discussion and analysis of operating results and changes in accounting policies. The document explicitly states it is a half-year report summary and references the full half-year report. The length is about 4765 characters, which is sufficient to contain substantive financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data and analysis.
2017-08-28 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.